TLX 3.46% $20.31 telix pharmaceuticals limited

Understanding Telix, page-1192

  1. 2,138 Posts.
    lightbulb Created with Sketch. 549
    https://www.linkedin.com/jobs/view/3976364231

    Global Lead - Renal Cancer Imaging

    We are seeking an experienced Oncology Imaging expert to join the Clinical Development team. The successful candidate will be responsible for design and execution of imaging studies using standard and advanced radiological techniques and analyzing and interpreting data from these studies to advance the development of novel diagnostic and therapeutic radiopharmaceuticals.

    The Global Lead - Renal Cancer Imaging will work closely in a matrix organisation with the respective Global Clinical Leads, Global Program Leads, Clinical Operations, Biostatistics and other relevant cross-functional teams to advance Telix Group’s assets towards the clinic. This will be undertaken via a deep working knowledge of advances in imaging in oncology.

    Develop and execute on imaging studies to enable the advancement of diagnostic and therapeutic radiopharmaceuticals

    Lead development of imaging sections of clinical study documentation and regulatory documents

    Lead the design, analysis, review, and quality control of imaging data to ensure accuracy and quality

    Oversight of third-party vendors, such as imaging CROs

    Collaborate with Global Clinical Leads, Global Program Leads, Biostatistics, Clinical Operations, and other cross-functional colleagues to ensure strategic and effective implementation of novel imaging approaches in clinical studies

    Prepare and deliver presentations, proposals, and reports for senior management, partners, and other stakeholders

    10+ years of experience in clinical imaging using CT and PET

    5+ years of experience in clinical development within the pharmaceutical or biotechnology industry

    Strong knowledge of clinical trial design, methodology, and regulatory requirements

    Track record of working effectively with imaging CROs and vendor management

    Experience in authoring clinical study and regulatory documents

    Experience in oncology


 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
(20min delay)
Last
$20.31
Change
0.680(3.46%)
Mkt cap ! $6.796B
Open High Low Value Volume
$20.22 $20.43 $19.94 $39.67M 1.963M

Buyers (Bids)

No. Vol. Price($)
1 100 $20.30
 

Sellers (Offers)

Price($) Vol. No.
$20.31 29999 1
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
TLX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.